| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
Ann Thorac Surg 1995;60:405-410
© 1995 The Society of Thoracic Surgeons
Section of Cardiovascular Research, Mayo Clinic and Mayo Foundation, Rochester, Minnesota
Accepted for publication April 4, 1995.
Background. Protamine sulfate, which is used for heparin neutralization, has been reported to induce catastrophic pulmonary vasoconstriction after infusion. However, in the systemic circulation, protamine infusion induces hypotension due to peripheral vasodilatation.
Methods. To determine whether protamine also could induce vasodilatation in the pulmonary circulation, third-order canine pulmonary artery segments were studied in vitro in organ chambers.
Results. In pulmonary artery segments that were caused to contract with phenylephrine (10-5 mol/L), protamine sulfate (40 to 400 µg/mL, final organ bath concentration) produced concentration-dependent relaxation in canine pulmonary artery segments with endothelium (to 74% ± 7% of the initial contraction to phenylephrine) that was significantly greater (p < 0.05) than in segments without endothelium (30% ± 6% of the initial phenylephrine contraction). Pretreatment of arterial segments with NG-monomethyl-L-arginine (10-5 mol/L), the competitive inhibitor of nitric oxide synthesis from L-arginine, did not change tension of arterial segments, but NG-monomethyl-L-arginine attenuated the relaxation to protamine. The inhibitory effect of NG-monomethyl-L-arginine could be reversed by the addition of L-arginine (10-4 mol/L) but not D-arginine (10-4 mol/L). Endothelium-dependent vasodilation to protamine (40 to 400 µg/mL) also could be inhibited by heparin (8 U/mL, final organ bath concentration). However, the inhibitory effect of heparin could be overcome by adding higher concentrations of protamine.
Conclusions. Protamine-mediated pulmonary vasodilatation could be an important mechanism to protect against the constrictive effects of autocoids generated during heparin neutralization. Such a mechanism might be dysfunctional in certain persons and put them at risk for pulmonary vasoconstriction after protamine infusion.
This article has been cited by other articles:
|
|
 |
|
  Y. Hamada, Y. Kameyama, H. Narita, K. T. Benson, and H. Goto Protamine After Heparin Produces Hypotension Resulting from Decreased Sympathetic Outflow Secondary to Increased Nitric Oxide in the Central Nervous System Anesth. Analg., January 1, 2005; 100(1): 33 - 37. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. Panos, X. Orrit, C. Chevalley, and A. Kalangos Dramatic post-cardiotomy outcome, due to severe anaphylactic reaction to protamine Eur. J. Cardiothorac. Surg., August 1, 2003; 24(2): 325 - 327. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
I. Golbasi, C. Nacitarhan, S. Ozdem, C. Turkay, H. Karakaya, G. Sadan, and O. Bayezid The inhibitory action of protamine on human internal thoracic artery contractions: the effect of free hemoglobin Eur. J. Cardiothorac. Surg., June 1, 2003; 23(6): 962 - 968. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 F. Viaro, M. B. Dalio, and P. R. B. Evora MD Catastrophic Cardiovascular Adverse Reactions to Protamine Are Nitric Oxide/Cyclic Guanosine Monophosphate Dependent and Endothelium Mediated* : Should Methylene Blue Be the Treatment of Choice? Chest, September 1, 2002; 122(3): 1061 - 1066. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. C. Body and S. K. Shernan The Utility of Nitric Oxide in the Postoperative Period Seminars in Cardiothoracic and Vascular Anesthesia, March 1, 1998; 2(1): 4 - 30. [Abstract] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| ANN THORAC SURG | ASIAN CARDIOVASC THORAC ANN | EUR J CARDIOTHORAC SURG |
| J THORAC CARDIOVASC SURG | ICVTS | ALL CTSNet JOURNALS |
